Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07729397) titled 'Autologous IC-Nine, CD30 CAR, and Constitutive IL7R Expressing EBVST for CD30 Lymphoma (ANCILE-30)' on July 22.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: The Methodist Hospital Research Institute
Condition:
Diffuse Large B-Cell Lymphoma (DLBCL)
Hodgkin Lymphoma
Peripheral T-cell Lymphoma (PTCL)
Anaplastic Large Cell Lymphoma, ALK-Positive
Anaplastic Large Cell Lymphoma, ALK-Negative
Intervention:
Biological: Autologous C7R.CD30-CAR-EBVSTs...
Recruitment Status: Not recruiting
P...